Digital Technologies Enhance Adverse Drug Reaction Reporting, Experts Say
Date: Saturday, July 15, 2023In a recent session at the 9th International Pharmaceutical Exhibition (iPHEX) held in Hyderabad, experts highlighted the significance of leveraging digital technologies for adverse drug reactions (ADRs) reporting. This approach not only helps evaluate our ability to detect signals of adverse events but also enables effective regulatory decision-making in a timely manner to ensure patient safety. The event, organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) with support from the Union commerce ministry, provided a platform to discuss these crucial aspects. Dr. Viranchi Shah, the national president of the Indian Drug Manufacturers' Association (IDMA), moderated the session.The Indian Pharmacopoeia Commission (IPC), based in Ghaziabad, had introduced a physical format for voluntary reporting of suspected ADRs by healthcare professionals three years ago as part of…
